Management Strategies for Hypercortisolism

This episode, titled ‘Management Strategies for Hypercortisolism,’ features panelists discussing the practical considerations involved in long-term management of hypercortisolism and the importance of maintaining sustained disease control while minimizing treatment-related complications. The expert faculty examine the factors that prompt treatment modification, emphasizing that management decisions extend beyond biochemical markers alone. They explore how clinicians balance cortisol normalization with the risk of adrenal insufficiency, medication-related adverse events, persistent comorbidities, and the potential for disease progression or recurrence.

The panel of experts highlights the importance of individualized monitoring strategies, including the use of biochemical assessments and clinical outcomes to guide dose adjustments and treatment selection over time. They discuss how persistent metabolic complications, despite apparent cortisol control, may necessitate changes in therapy and reinforce the need for aggressive management of cardiovascular and metabolic risk factors alongside cortisol-directed treatment.

The discussion also focuses on strategies for preventing recurrence and achieving durable disease control. Panelists review the long-term recurrence risk associated with certain forms of hypercortisolism and emphasize the value of ongoing surveillance, patient education, and convenient monitoring tools that can support earlier detection of disease recurrence. They note that treatment plans often require flexibility, particularly when surgery is not curative or when additional therapies are needed to maintain remission.

Finally, the expert endocrinologists underscore the importance of setting realistic expectations with patients and fostering strong communication throughout the treatment journey. They explain how educating patients about recovery timelines, treatment goals, and potential challenges can improve adherence and engagement. The panel concludes by discussing multidisciplinary collaboration and the need for greater awareness across specialties to improve recognition and management of hypercortisolism in high-risk populations.

In the last episode, ‘Integrating Hypercortisolism Screening into Clinical Practice,’ panelists will discuss best practices for identifying patients who may benefit from screening, implementing targeted diagnostic approaches, and improving collaboration across specialties to reduce delays in diagnosis. They also highlight the importance of determining the underlying cause of hypercortisolism and pursuing appropriate, potentially curative treatment strategies.